Drug firms ‘try to keep prices high’

DRUGS companies are doing everything they can to maintain the high price of medicine, including buying off companies that could sell them for less.

European Commission officials carried out surprise raids on pharmaceutical companies to gather evidence of anti-competitive practices in the multi-billion euro industry.

They found emails and other evidence that showed how companies were obstructing efforts to make cheaper medicines available for ailments from cancer and heart disease to pain.